Section 32
Not publicly disclosed in the reviewed sources. · seed, series-a, growth · US, Global
Concentrated frontier-technology and life-sciences venture firm.
Tier 2 · ranked #74biodeep-tech
Visit / pitchOfficial siteOpen in the live directory
Key facts
| Fund size | Team reports experience backing 500+ companies and driving 150+ exits. |
| Stage | seed, series-a, growth |
| Typical first check | Not publicly disclosed in the reviewed sources. |
| Sectors | bio, ai, deep-tech, health |
| Geography | US, Global |
| Status | open |
Always confirm on the official page before applying — dates and terms change.
Background
Concentrated frontier-technology and life-sciences venture firm. This pass separates published fund behavior from private mechanics and catalog assumptions.
How the application really works
No dedicated public pitch route was confirmed; route through a relevant investor's published professional profile or a trusted introduction.
Tips
- Show direct fit to seed / series-a / growth and the published thesis.
- Route to a named investor whose current remit matches the company.
- State geography, round size, traction and why this firm is the right partner.
Watch out for
- Outside the published stage, geography or sector mandate.
- Treating a generic media or LP channel as a founder intake.
- Assuming unpublished check, ownership or timing data.
Track record
- Current team page attributes 30+ IPOs and 50+ category leaders to Bill Maris's investment history.
No comparable acceptance rate is published.
Investment thesis
AI, computational biology, physical AI, infrastructure, cybersecurity and enterprise.
How to reach them
- No dedicated public pitch route was confirmed; route through a relevant investor's published professional profile or a trusted introduction.
Notable portfolio
CohereDatabricksScale AICoinbase
Frequently asked questions
- What stages does the fund target?
- seed, series-a, growth
- Where does it invest?
- US, Global
- What is the latest disclosed vehicle or capital base?
- Not published in the reviewed sources.
- What check size does it write?
- Not publicly disclosed in the reviewed sources.
- How can a founder approach the firm?
- No dedicated public pitch route was confirmed; route through a relevant investor's published professional profile or a trusted introduction.
- What remains unknown?
- Investment acceptance rate is not published. latest fund size is not publicly disclosed. latest fund vintage is not publicly disclosed. check min is not publicly disclosed.
Related venture funds
Sources
- www.s32.com — Current official strategy, geography and activity. (checked 2026-08-10)
- www.s32.com/team — Current official investing-team roster. (checked 2026-08-10)